1 Dimagno EP .Pancreatic cancer: clinical presentation, pitfallsand early clues[J].Ann Oncol,1999, 10 Suppl 4:, 140.
2 Van Rees BP, Tascilar M, Hruban RH, et al. Remote partial gastrect omy as a riskfactor for pancreatic cancer: potential for preventive strategie s[J]. Ann Oncol,1999, 10 Suppl 4: 204.
3 Nakaizumi A, Uehara H, Takenaka A, et al.Diagnosis of pancreatic cancer bycytology and measurement of oncogene and tumor markers in pure pancre atic juice aspiratedby endoscopy[J]. Hepatogastroenterology, 1999 , 46:25, 31.
3Andre T, Balosso J,Louvet C,et al. Adenocarcinoma of the pancreas: General characteristics[J]. Presse-Med, 1998;27(11):533-536.
4Jemal A,Siegel R,Ward E,et al.Cancer Statisties,2007[J].CA Cancer J Clin,2007;57(1):43-66.
5Sohn TA,Yeo CJ,Cameron JL,et al. Resected adenocarcinoma of the Pancreas-616 patients: results,outcomes,and Prognostic indicators[J]. J Gastrointest Surg,2000;4(6):567-579.
6Hermanek P.Staging of exocrine pancreatic carcinoma[J].Eur J Surg Oncol,1991;17:167.
7Micke O,Bnms F, Kurowski R,et al. Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy[J]. Int J Radiation Oncology Biol Phys,2003;57(1):90-97.
8Legmann P,Vignaux W, Dousset B,et al.Pancreatic tumors: comparison of dual-phase helical CT and endoscopic conography[J]. AJR Am J Roentgenol, 1998; 170(5): 1315- 1319.
9Cantore M,Pederzoli P, Comalba G,et al. Intza-arterial chemotherapy for unresectable pancreatic cancer[J]. Ann Oncol,2000; 11(5):569-573.
10Aigner KR, Gailhofer S,Kopp S. Regional versus systemic chemotherapy for advanced pancreatic cancer:a randomized study[J]. Hepatogastroenterology,1998;45 (22): 1125-1129.
